Comprehensive Study Guide: Drugs for Upper Respiratory Disorders
Overview of Upper Respiratory Disorders and Etiology
- Common Upper Respiratory Infections:
* Common Cold: Primarily caused by the rhinovirus. It specifically affects the nasopharyngeal tract.
* Acute Rhinitis: Characterized by the inflammation of the nasal mucous membranes.
* Allergic Rhinitis: Also known as Hay Fever, this is caused by pollen or foreign substances.
* Acute Pharyngitis: Refers to the inflammation of the throat.
- Upper vs. Lower Respiratory System Anatomy:
* Upper Respiratory System: Includes the nasal cavity, pharynx, and larynx.
* Lower Respiratory System: Includes the trachea, bronchi, bronchioles, and alveoli. Severe conditions in this area affect the lungs.
- Common Cold Characteristics:
* Contagious Period: Individuals are contagious for 1 to 4 days before the onset of symptoms and during the first 3 days of the cold.
* Transmission: Occurs via touching contaminated surfaces and then touching the nose or mouth, or via viral droplets from sneezing.
* Symptoms: Nasal congestion, nasal discharge, cough, and increased mucosal secretions.
Histamine: Physiology and Receptor Stimulation
- Distribution: Histamine is found in specialized cells throughout practically all tissues. Concentration is especially high in the skin, lungs, and GI tract, while it remains low in the plasma.
- Specialized Cells:
* Periphery: Found in mast cells and basophils.
* Central Nervous System (CNS): Found in neurons.
- Physiological Roles: Involved in allergic reactions, regulation of gastric acid and secretion, and the sleep-waking cycle.
- H1 Receptor Stimulation Effects:
* Vasodilation: Affects the skin of the face and upper body; extensive stimulation can cause hypotension.
* Capillary Permeability: Increased permeability leads to edema.
* CNS Effects: Plays a role in cognition, memory, and sleep-waking cycles.
* Other Effects: Causes itching, pain, and the secretion of mucus.
- H2 Receptor Stimulation Effects:
* Gastric Acid Secretion: Acts directly on parietal cells in the stomach to promote acid release. This is the dominant role of the H2 receptor.
Antihistamines (H1 and H2 Antagonists)
- H2 Antagonists: Produce selective blockade of H2 receptors; used primarily for the treatment of gastric and duodenal ulcers.
- H1 Antagonists (Classes): Divided into two major groups based on their ability to cross the blood-brain barrier and cause sedation.
* First-Generation H1 Antagonists: Highly sedating; they work both peripherally and centrally.
* Second-Generation H1 Antagonists: Non-sedating or have negligible CNS depression; they work peripherally and have fewer side effects.
- Mechanism of Action (MOA): H1 antagonists block the actions of histamine at H1 receptors. They do not block H2 receptors. Some first-generation agents also bind to muscarinic receptors (anticholinergic effect).
- Pharmacologic Effects:
* Peripheral: Reduces localized flushing, itching, and pain.
* CNS (Therapeutic Dose): First-generation causes CNS depression. Second-generation has negligible effects.
* Overdose: Can lead to CNS stimulation and convulsions. Young children are exceptionally sensitive to this stimulation.
Diphenhydramine (First-Generation H1 Antagonist)
- Action: Competes with histamine for receptor sites to prevent the histamine response. It reduces nasopharyngeal secretions, itching, and sneezing.
- Therapeutic Uses:
* Mild allergy and Allergic Rhinitis.
* Prevention of motion sickness (acts as an adjunct).
* Ingredient in cold preparations and OTC sleep aids.
* Treatment for mild symptoms of Parkinsonism (due to anticholinergic effects).
- Contraindications and Cautions:
* Severe liver disease.
* Narrow-angle glaucoma (NAG) due to increased intraocular pressure.
* Urinary retention.
- Side Effects: Drowsiness, dry mouth, dizziness, blurred vision, wheezing, photosensitivity, constipation, GI distress, and blood dyscrasias. Often referred to by the mnemonic "Anti-SLUDGE" (Anti-Salivation, Lacrimation, Urination, Defecation, Gastric emptying).
- Drug-Drug Interactions:
* Increased CNS depression with alcohol, opioids, hypnotics, benzodiazepines, and antidepressants.
* MAOIs: Avoid use as they prolong and intensify the anticholinergic effects of antihistamines.
- Nursing Interventions and Patient Teaching:
* Obtain a list of environmental exposures, current drugs, and stressors.
* Administer with food to decrease GI distress.
* Avoid operating motor vehicles if drowsiness occurs.
* Advise against alcohol and other CNS depressants.
* Suggest sugarless candy, gum, or ice chips for dry mouth relief.
Special Populations and High-Risk Patients for Antihistamines
- Pregnancy: Classified as Pregnancy Category B; use with caution.
- Nursing Mothers: Small amounts pass into breast milk; use is generally discouraged.
- Newborns: Should not use antihistamines as they may lead to seizures.
- Children: Not to be used for children under 2 years of age. Young children may exhibit nightmares, nervousness, and irritability.
- Elderly: More likely to experience confusion, difficult or painful urination, dizziness, drowsiness, faintness, and dryness of the mouth/nose/throat.
Comparison of Antihistamine Generations and Examples
- First-Generation Examples: Diphenhydramine, hydroxyzine, promethazine, clemastine, chlorpheniramine.
- Second-Generation Examples: Cetirizine, fexofenadine, loratadine, azelastine (nasal spray), and azelastine combined with fluticasone.
- Duration of Action: Second-generation agents typically have a longer duration of action, which increases patient compliance.
Nasal Congestion and Decongestants
- Etiology: Caused by the dilation of nasal blood vessels and swelling of the nasal cavity during infection or allergy.
- Nasal Decongestants (Mechanism): Stimulate alpha-adrenergic receptors to produce nasal vascular constriction. This shrinks the mucous membranes and reduces secretions.
- Systemic Decongestants: Examples include pseudoephedrine and phenylephrine. These are alpha-adrenergic agonists that cause generalized vasoconstriction.
- Topical Decongestants: Nasal sprays or drops (e.g., oxymetazoline, tetrahydrozoline).
* Tolerance and Rebound: Prolonged use can cause rebound nasal congestion. Patients should not use topical decongestants for more than 3 days.
- Contraindications: Use with extreme caution in patients with hypertension, hyperthyroidism, and diabetes mellitus.
- Interactions:
* Pseudoephedrine can decrease the effects of beta-blockers.
* MAOIs can increase the risk of hypertension or cardiac dysrhythmias.
* Caffeine increases restlessness and palpitations.
Intranasal Glucocorticoids
- Action: Anti-inflammatory action that decreases rhinorrhea, sneezing, and congestion.
- Usage: Used for allergic rhinitis, either alone or in combination with H1 antihistamines.
- Drug Examples: Beclomethasone, budesonide, flunisolide, fluticasone, mometasone, triamcinolone.
- Side Effects: Headache, blurred vision, irritated or dry nasal mucosa, pharyngitis, hoarseness, nausea, vomiting, candidiasis, and insomnia.
Antitussives and Expectorants
- Antitussives:
* Action: Act on the cough-control center in the medulla to suppress the cough reflex.
* Types: Nonopioid (e.g., benzonatate, dextromethorphan) and Opioids (e.g., codeine).
* Combinations: Often grouped as Guaifenesin + codeine.
- Expectorants (Guaifenesin):
* Action: Loosens bronchial secretions so they can be eliminated by coughing.
* Use: Common cold and dry, nonproductive cough.
* Side Effects: Drowsiness, dizziness, headache, nausea, vomiting, diarrhea.
* Patient Teaching: Advise the patient to drink at least 8 glasses of water per day to help loosen mucus.
Sinusitis and Pharyngitis Treatments
- Sinusitis: Inflammation of the sinus mucous membranes. Treated with decongestants, acetaminophen, fluids, rest, and occasionally antibiotics.
- Acute Pharyngitis: Inflammation of the throat. Treated with saline gargles, lozenges, increased fluid intake, and acetaminophen.